(MT Newswires) -- Moderna Inc. co-founder and Chairman Noubar Afeyan talks about the state of the biotechnology industry and the challenges it faces. He also discusses the vaccine maker's strategy, and how the industry can utilize artificial intelligence. He speaks with Francine Lacqua on the sidelines of the New Economy Forum in Singapore.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164 USD | +0.42% | +27.08% | +64.92% |
05-23 | Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... | |
05-23 | The market is good to go until Nvidia’s next quarterly results |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B | |
-7.97% | 11.28B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Chairman Afeyan on Industry Outlook, Strategy, AI